RLAY - Relay Therapeutics GAAP EPS of -$0.78 misses by $0.09 revenue of $0.22M beats by $0.06M
2023-05-04 18:07:32 ET
- Relay Therapeutics press release ( NASDAQ: RLAY ): Q1 GAAP EPS of -$0.78 misses by $0.09 .
- Revenue of $0.22M (-47.6% Y/Y) beats by $0.06M .
- Shares -1.96% AH.
For further details see:
Relay Therapeutics GAAP EPS of -$0.78 misses by $0.09, revenue of $0.22M beats by $0.06M